Synopsys has ridden a powerful multi year run, and with the stock around US$494 at the last close the real issue for investors is whether that price still lines up with the cash the business is expected to generate. Recent AI heavy partnerships have sharpened that question rather than settled it.
The issue now is whether Synopsys' current share price is adequately supported by its projected cash flows when analyzed through a Discounted Cash Flow (DCF) lens.
If you are weighing Synopsys against other AI exposed opportunities, it can help to compare its setup with a broader group of 39 profitable AI stocks that aren't just burning cash.
The Discounted Cash Flow (DCF) model here focuses on the cash Synopsys can return to shareholders over time rather than near term earnings moves. Latest twelve month free cash flow sits around $2.7b, and the model assumes that this pool of cash continues to grow rather than shrink, which pushes more value into later years of the forecast.
Analysts and internal estimates used in the DCF point to rising free cash flow into the early 2030s, with growth tapering as Synopsys matures rather than chasing extreme hockey stick curves. Because the recent OpenAI and Amazon agreements point to longer duration licensing and royalty streams, the model uses a multi stage profile in which early years do more of the lifting, and later years still contribute meaningfully but with slower expansion. Despite the AI focused deals and the current share price of $494.51 already reflecting strong expectations, the DCF projections put Synopsys' estimated intrinsic value meaningfully above the current share price, so the market is still treating those future cash flows cautiously. Find out what Synopsys could be worth using our Discounted Cash Flow (DCF) estimate.
Synopsys Narratives on Simply Wall St pick up where the DCF puzzle leaves off and spell out which paths for growth, profitability and earnings would need to play out for the stock to be worth materially more or less than today’s price. Each scenario ties its number to a specific view on how Synopsys' expansion, margins and risk profile could evolve, giving you a reference point you can revisit as fresh information comes through.
One of the top community narratives on Synopsys: 13% undervalued
"The view that Synopsys is undervalued suggests the current share price does not fully reflect the company’s raised FY26 guidance..."
Discover why this Narrative puts Synopsys at 13% undervalued.
Before making any final judgment on Synopsys, it helps to understand who is steering the ship, how their incentives are structured, and whether those rewards truly line up with your interests. See who runs Synopsys and how they are paid.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com